FDA inspection
Henan Lihua Pharmaceutical Co., Ltd.: FDA inspection ending Dec 14, 2017
FDA inspection 1035957 · Official Action Indicated (OAI) · Anyang
Key facts
| Inspection ID | 1035957 |
|---|---|
| Firm | Henan Lihua Pharmaceutical Co., Ltd. |
| FEI number | 3001164052 |
| Address | Middle Of Huanghe Street |
| City | Anyang |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | Dec 14, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 455000 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data